Brief: Guard Therapeutics Receives Regulatory EU Approvals
Aug 8 (Reuters) - Guard Therapeutics International AB
(publ) GUARD.ST :
* GUARD THERAPEUTICS RECEIVES REGULATORY EU APPROVALS TO
INCLUDE
PATIENTS IN ITS PHASE 2B STUDY POINTER
Source text for Eikon: ID:nMFN4hR9Gc
Further company coverage: GUARD.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover